The report "Analytical Standards Market by Technique (GC, LC, TLC, IR, MS, NMR, Titrimetry), Category (Organic, Inorganic), Method (Bioanalytical, Dissolution), Application (F&B, Environmental, Pharma, Clinical Diagnostic, Forensics), Region - Global Forecast to 2030", size is projected to reach USD 2.16 billion by 2030 from USD 1.53 billion in 2024, growing at a CAGR of 5.9% during the forecast period.
Browse 422 market data Tables and 56 Figures spread through 409 Pages and in-depth TOC on "Analytical Standards Market by Technique (GC, LC, TLC, IR, MS, NMR, Titrimetry), Category (Organic, Inorganic), Method (Bioanalytical, Dissolution), Application (F&B, Environmental, Pharma, Clinical Diagnostic, Forensics), Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/analytical-standards-market-8484789.html
The major factors driving the market growth of the analytical standards market include increasing adoption of analytical techniques in pesticide monitoring, the rising R&D investment for research and impending patent cliff. The growing safety standards for pharmaceutical and biotechnology industries are further high growth prospects for the analytical standards market during the forecast period. Moreover, the intense competition among players can support brand protection efforts. The development of new drugs adhering to GMP regulations provide opportunities for market growth
The spectroscopy segment is to register a significant growth over the forecast period of 2024-2030.
Based on the technique, over the forecast period of 2024-2030, the spectroscopy segment is to register a significant growth. The analytical standards market is segmented into spectroscopy, chromatography, titrimetry and physical property testing. The analytical standards ‘spectroscopy’ market includes mass spectroscopy, atomic absorption spectroscopy, IR spectroscopy, nuclear magnetic resonance spectroscopy, X-ray fluorescence/diffraction spectroscopy and UV/Vis spectroscopy. The key factors encouraging the growth of spectroscopy segment during the forecast period are the increased adoption of drug development R&D and the rising use of spectroscopic techniques across a broad range of application areas.
The pharmaceutical & life sciences standards segment accounted for the largest share of analytical standards in 2024-2030.
Based on application, during the forecast period, the pharmaceutical & life science standards segment is anticipated to dominate the analytical standards market, holding the largest market share. The pharmaceutical & life science standards segment commands a significant share due to the stringent regulations, increasing focus on quality control and increasing awareness for pharmaceutical & life sciences analytical standards across key markets (such as the US, Europe, China, India, and the Middle East).
Asia Pacific registered the highest CAGR in the market during the forecast period.
In 2024, Asia Pacific is expected to register the highest CAGR in the market for analytical standards during the forecast period. Asia Pacific comprises China, India, South Korea, Taiwan, and Singapore, and the rest of Asia Pacific. Factors such as the presence of stringent regulatory policies for food and drug safety and the growth of the biotechnology and pharmaceutical industries are driving the growth of the APAC analytical standards market during the forecast period.
As of 2023, prominent players in analytical standards are Merck KGaA (Germany), Agilent Technologies, Inc. (US), Waters Corporation (US), LGC Limited (UK), PerkinElmer (US), Restek Corporation (US), SPEX CertiPrep (US), AccuStandard (US), Thermo Fisher Scientific, Inc. (US), Mallinckrodt (UK), The United States Pharmacopeial Convention (US), Cayman Chemical (US), RICCA Chemical Company (US) and GFS Chemicals, Inc. (US) among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/